Brief: Emcure Pharmaceuticals Says US FDA Conducted PAI At Emcure's Sanand Facility
09/07/2025 13:52
July 9 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: US FDA CONDUCTED PAI AT EMCURE'S SANAND FACILITY INSPECTION CONCLUDED WITH ZERO OBSERVATIONS Source text: ID:nBSE36yqc9 Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees